GNA13 and hepatocellular carcinoma: In conclusion, we propose that UPF1 is an HCC repressor that acts by regulating the lncRNA-HEIH/miR-194-5p/GNA13 axis; in addition, it has wide-ranging therapeutic applications and is a promising biomarker for HCC.